AMPLEXA GENETICS A/S: Financial statements 2022
CVR: 29428441
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,494,691 and a net result of DKK -2,282,128 compared with DKK 12,328,350 the year before. That is a decrease of 72.9% compared with the year before. Equity in the 2022 report amounted to DKK -14,490,612. The company had 14 employees in the financial year.
- Gross Profit
- DKK 5,494,691
- Profit/Loss
- DKK -2,282,128
- Equity
- DKK -14,490,612
- Total Assets
- DKK 12,283,953
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 5.5 mio. | -2.3 mio. | -14.5 mio. | 14 |
| 2021 | - | 20.3 mio. | 12.3 mio. | -12.2 mio. | 13 |
| 2020 | - | 12.4 mio. | 5.9 mio. | -24.5 mio. | 7 |
| 2019 | - | 2.8 mio. | -1.5 mio. | -30.4 mio. | 7 |
| 2018 | - | 907 t. | -3.7 mio. | -28.9 mio. | 7 |
Official annual report
Keep an eye on AMPLEXA GENETICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AMPLEXA GENETICS A/S has published its annual report for 2021. Gross profit came to DKK 20,278,070, and the net result was DKK 12,328,350.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.